Latest filing published 01 Mar 2017 for ALEXION PHARMACEUTICALS INC, €107k.
Filing timeline
BuySaleInsider track record
Clare Carmichael: trading record in brief
This profile gathers the share dealings of Clare Carmichael across 2 companies, led by Alexion Pharmaceuticals Inc and Watson Pharmaceuticals Inc. The record holds 57 filings, for trades running from 12 August 2008 to 1 March 2017.
Every open-market trade on record is a sale: 40 sales worth €4.4M. Other entries cover 15 share grants and 2 option exercises. So far in 2017, the count stands at no purchases and 7 sales.
The latest filing, published on 1 March 2017, reports an open-market sale of €107k in Alexion Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Clare Carmichael
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 860 shares@ US$131.206.6% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-17-000055:0
- 915 shares@ US$131.717.0% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-17-000055:1
- 6,500 shares0Common Stock, par value $.0001 per shareSEC:0000899866-17-000055:2
- 404 shares@ US$132.503.1% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-17-000055:3
- 167 shares@ US$126.841.2% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-17-000038:0
- 3,380 shares@ US$125.6924.3% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-17-000031:0
- 24 shares@ US$126.650.2% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-17-000031:1
- 166 shares@ US$128.091.2% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-17-000031:2
- 1,000 shares@ US$127.767.1% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-16-000347:0
- 165 shares@ US$137.141.3% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-16-000340:0
- 7,000 shares0Common Stock, par value $.0001 per shareSEC:0000899866-16-000266:0
- 1,312 shares@ US$138.9110.3% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-16-000266:1
- 203 shares@ US$143.814.3% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-16-000243:0
- 4 shares@ US$145.130.1% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-16-000243:1
- 11,763 sharesCommon Stock, par value $.0001 per shareSEC:0000899866-16-000243:2
- 100 shares@ US$145.382.1% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-16-000243:3
- 100 shares@ US$143.582.1% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-16-000243:5
- 79 shares@ US$139.131.6% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-16-000243:10
- 400 shares@ US$141.428.3% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-16-000243:7
- 2,401 shares@ US$138.0248.8% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-16-000243:11
- 160 shares@ US$142.153.3% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-16-000243:6
- 300 shares@ US$144.336.3% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-16-000243:4
- 933 shares@ US$140.4419.2% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-16-000243:8
- 185 shares@ US$138.023.8% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-16-000243:9
- 305 shares@ US$168.62Common Stock, par value $.0001 per shareSEC:0000899866-15-000169:0
25 of 57 declarations
